Overview

This is a Study to Determine the Antidepressant Effects of AZD6765

Status:
Completed
Trial end date:
2011-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the antidepressant effects of AZD6765 compared to placebo.
Phase:
Phase 2
Details
Lead Sponsor:
AstraZeneca
Collaborator:
National Institute of Mental Health (NIMH)
Treatments:
Antidepressive Agents